Neil Gagnon Biography and Net Worth

Major Shareholder of Apollo Endosurgery


Neil Gagnon is the Major Shareholder of Apollo Endosurgery.

What is Neil Gagnon's net worth?

The estimated net worth of Neil Gagnon is at least $0.00 as of February 13th, 2024. Gagnon owns 597,149 shares of Apollo Endosurgery stock worth more than $0 as of March 28th. This net worth approximation does not reflect any other investments that Gagnon may own. Learn More about Neil Gagnon's net worth.

How do I contact Neil Gagnon?

The corporate mailing address for Gagnon and other Apollo Endosurgery executives is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. Apollo Endosurgery can also be reached via phone at (512) 279-5100 and via email at [email protected]. Learn More on Neil Gagnon's contact information.

Has Neil Gagnon been buying or selling shares of Apollo Endosurgery?

Neil Gagnon has not been actively trading shares of Apollo Endosurgery in the last ninety days. Most recently, on Monday, April 5th, Neil Gagnon bought 303 shares of Apollo Endosurgery stock. The stock was acquired at an average cost of $5.48 per share, with a total value of $1,660.44. Following the completion of the transaction, the insider now directly owns 402,580 shares of the company's stock, valued at $2,206,138.40. Learn More on Neil Gagnon's trading history.

Who are Apollo Endosurgery's active insiders?

Apollo Endosurgery's insider roster includes John Barr (Director), Jeffrey Black (CFO), Neil Gagnon (Major Shareholder), Chas Mckhann (CEO), and David Pacitti (Director). Learn More on Apollo Endosurgery's active insiders.

Neil Gagnon Insider Trading History at Apollo Endosurgery

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2021Buy303$5.48$1,660.44402,580View SEC Filing Icon  
2/5/2021Buy30,954$4.71$145,793.34382,470View SEC Filing Icon  
2/3/2021Buy28,388$4.46$126,610.48351,516View SEC Filing Icon  
See Full Table

Neil Gagnon Buying and Selling Activity at Apollo Endosurgery

This chart shows Neil Gagnon's buying and selling at Apollo Endosurgery by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Apollo Endosurgery Company Overview

Apollo Endosurgery logo
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $9.94
Low: $9.87
High: $10.00

2 Week Range

Now: N/A

Volume

1,658,800 shs

Average Volume

1,432,125 shs

Market Capitalization

$579.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.31